Rice Megan S, Bertrand Kimberly A, VanderWeele Tyler J, Rosner Bernard A, Liao Xiaomei, Adami Hans-Olov, Tamimi Rulla M
Clinical and Translational Epidemiology Unit, Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Bartlett 9, Boston, MA, 02116, USA.
Slone Epidemiology Center, Boston University, Boston, MA, USA.
Breast Cancer Res. 2016 Sep 21;18(1):94. doi: 10.1186/s13058-016-0750-0.
High mammographic density (MD) is a strong risk factor for breast cancer. However, it is unclear whether high MD is an intermediate phenotype or whether breast cancer risk factors influence breast cancer risk and MD independently.
Our study population included 1290 invasive breast cancer cases and 3422 controls from the Nurses' Health Studies. We estimated the percent of the total association between the risk factor and breast cancer that was mediated by MD.
In both pre- and postmenopausal women, the association between history of biopsy-confirmed benign breast disease and risk was partially mediated by percent MD (percent mediated (PM) = 17 %, p < 0.01 and PM = 33 %, p = 0.04, respectively). In premenopausal women, the associations between early life body size (adolescent somatotype and BMI at age 18) and breast cancer risk were substantially mediated by percent MD (PM = 73 %, p = 0.05 and PM = 82 %, p = 0.04, respectively). In postmenopausal women, the proportion of the associations of childhood somatotype and adolescent somatotype that were mediated by percent MD were lower (PM = 26 %, p = 0.01 for both measures). Hormone therapy use at mammogram was significantly mediated by percent MD in postmenopausal women (PM = 22 %, p < 0.01). Associations with other risk factors, such as age at menarche or family history of breast cancer, were not mediated by percent MD.
Percent MD partially mediated some of the associations between risk factors and breast cancer, though the magnitude varied by risk factor and menopausal status. These findings suggest that high MD may be an intermediate in some biological pathways for breast cancer development.
乳腺钼靶高密度(MD)是乳腺癌的一个重要危险因素。然而,目前尚不清楚高MD是一种中间表型,还是乳腺癌危险因素独立地影响乳腺癌风险和MD。
我们的研究人群包括来自护士健康研究的1290例浸润性乳腺癌病例和3422例对照。我们估计了由MD介导的危险因素与乳腺癌之间的总关联百分比。
在绝经前和绝经后女性中,活检确诊的良性乳腺疾病史与风险之间的关联部分由MD百分比介导(介导百分比(PM)分别为17%,p<0.01和33%,p=0.04)。在绝经前女性中,早年体型(青少年体型和18岁时的BMI)与乳腺癌风险之间的关联很大程度上由MD百分比介导(PM分别为73%,p=0.05和82%,p=0.04)。在绝经后女性中,儿童体型和青少年体型关联中由MD百分比介导的比例较低(两种测量方法的PM均为26%,p=0.01)。绝经后女性乳房X光检查时使用激素治疗显著由MD百分比介导(PM=22%,p<0.01)。与其他危险因素的关联,如初潮年龄或乳腺癌家族史,不由MD百分比介导。
MD百分比部分介导了一些危险因素与乳腺癌之间的关联,尽管其程度因危险因素和绝经状态而异。这些发现表明,高MD可能是乳腺癌发生的某些生物学途径中的一个中间因素。